Cargando…
VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
BACKGROUND: ABL1 is primarily known as a leukemia-related oncogene due to translocation, but about 2.2% of ABL1 mutations have been identified in bladder cancer, and high expression in solid cancer has also been detected. METHODS: Here, we used the NCBI database, UCSC genome browser gateway and Tand...
Autores principales: | Kim, Min-Hye, Yang, Gi-Eun, Jeong, Mi-So, Mun, Jeong-Yeon, Lee, Sang-Yeop, Nam, Jong-Kil, Choi, Yung Hyun, Kim, Tae Nam, Leem, Sun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097952/ https://www.ncbi.nlm.nih.gov/pubmed/33952249 http://dx.doi.org/10.1186/s12920-021-00968-1 |
Ejemplares similares
-
YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
por: Baek, Seung-Woo, et al.
Publicado: (2022) -
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
por: Roh, Yun-Gil, et al.
Publicado: (2018) -
Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells
por: Mun, Jeong-Yeon, et al.
Publicado: (2022) -
Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
por: Roh, Yun-Gil, et al.
Publicado: (2020) -
Possible Association of IL-4 VNTR Polymorphism with Susceptibility to Preeclampsia
por: Salimi, Saeedeh, et al.
Publicado: (2014)